Gilead Sciences, Inc.

NASDAQ:GILD   3:59:59 PM EDT
60.80
+0.13 (+0.21%)
5:02:16 PM EDT: $60.70 -0.10 (-0.16%)
Earnings Announcements

Gilead Sciences Says Is Now Meeting Real-Time Demand For Veklury In U.S.

Published: 10/01/2020 18:18 GMT
Gilead Sciences Inc (GILD) - Gilead Sciences Inc - Now Meeting Real-time Demand for Veklury in U.S. and Anticipates Meeting Global Demand for Veklury in Oct.
Gilead Sciences Inc - Anticipates Meeting Global Demand for Veklury in October, Even in Event of Potential Future Surges of Covid-19.
Gilead - Donated 1.5 Million Vials of Veklury, Gave Clinical Drug Supply at No Cost for Evaluation As Investigational Agent in Trials Around World.
Revenue is expected to be $6.44 Billion
Adjusted EPS is expected to be $1.97

Next Quarter Revenue Guidance is expected to be $6.97 Billion
Next Quarter EPS Guidance is expected to be $2.20

More details on our Analysts Page.